{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T14:44:30Z","timestamp":1784990670474,"version":"3.55.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Research in animal models on cerebral metabolism after brain injury highlights the potential benefits of ketosis in reducing secondary brain injury, but studies in humans are lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>This study aimed to examine if a 6-week ketogenic diet intervention with added medium-chain triglycerides (MCT) was feasible in adult patients with acquired brain injury in the subacute phase, whether ketosis could be achieved and maintained, and to what extent serious adverse reactions, adverse reactions, serious adverse events, and adverse events occured.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients \u226518 years of age diagnosed with subacute acquired brain injury and an expectation of hospitalisation \u22656 weeks were included in the intervention group. Patients not included in the intervention group were included in a standard care reference group. The intervention consisted of a ketogenic diet supplemented with MCT to obtain a plasma concentration of \u03b2-hydroxybutyrate (BHB) \u22650.5 mmol\/L. Patients who were enterally fed were given KetoCal\u00ae 2.5:1 LQ MCT Multi Fiber (Nutricia A\/S, Aller\u00f8d, Denmark), supplemented with Liquigen\u00ae (Nutricia A\/S, Aller\u00f8d, Denmark). Patients consuming oral nutrition were given KetoCal\u00ae 2.5:1 LQ MCT Multi Fiber supplemented with Liquigen\u00ae, in addition to ketogenic meals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>During a 13-week inclusion period, 12 of 13 eligible patients (92% [95% CI: 67% to 99%]) were included in the intervention group, and 17 of 18 excluded patients (94% [95% CI: 74% to 99%]) were included in the reference group. Eight patients (67%) completed the 6-week intervention. It took a median of 1\u2009day to achieve ketosis from starting a 100% MCT ketogenic diet, and it was maintained for 97% of the intervention period after ketosis was obtained. There were no serious adverse reactions to the MCT ketogenic diet, and patients experienced adverse reactions not considered serious in 9.5% of days with the intervention. The MCT ketogenic diet was accepted by patients on all intervention days, and in the two patients transitioning from enteral feeding to oral intake, there were no complications related to transitioning.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Intervention with MCT ketogenic diet is feasible and tolerated for 6\u2009weeks in hospitalised adult patients with subacute acquired brain injury. Randomised controlled trials are needed to assess the benefits and harms of the MCT ketogenic diet and the effect on patients\u2019 recovery.<\/jats:p><jats:p><jats:bold>Clinical trial registration:<\/jats:bold><jats:ext-link>ClinicalTrials.gov<\/jats:ext-link>, identifier [NCT04308577].<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1305888","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T16:09:31Z","timestamp":1710864571000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Diet-induced ketosis in adult patients with subacute acquired brain injury: a feasibility study"],"prefix":"10.3389","volume":"10","author":[{"given":"Maria G. P.","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens R.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek J.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian G.","family":"Riberholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"key":"ref1","volume-title":"Global burden of disease collaborative network Seattle, United States","year":"2019"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1474-442(18)30415-0","article-title":"Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"James","year":"2019","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1080\/02699052.2018.1429025","article-title":"The ketogenic diet as a treatment for traumatic brain injury: a scoping review","volume":"32","author":"McDougall","year":"2018","journal-title":"Brain Inj"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1172\/JCI105650","article-title":"Brain metabolism during fasting","volume":"46","author":"Owen","year":"1967","journal-title":"J Clin Invest"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10545-005-5518-0","article-title":"Cerebral ketone body metabolism","volume":"28","author":"Morris","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s00134-018-05517-6","article-title":"Boosting the injured brain with supplemental energy fuels","volume":"45","author":"Oddo","year":"2019","journal-title":"Intensive Care Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","article-title":"\u03b2-Hydroxybutyrate: a signaling metabolite","volume":"37","author":"Newman","year":"2017","journal-title":"Annu Rev Nutr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X18808947","article-title":"Modulation of cerebral ketone metabolism following traumatic brain injury in humans","author":"Bernini","year":"2018","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc10020","article-title":"Clinical review: ketones and brain injury","volume":"15","author":"White","year":"2011","journal-title":"Crit Care"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.jcbfm.9600543","article-title":"Cerebral metabolic adaptation and ketone metabolism after brain injury","volume":"28","author":"Prins","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.nut.2012.09.009","article-title":"Stimulation of mild, sustained ketonemia by medium-chain triacylglycerols in healthy humans: estimated potential contribution to brain energy metabolism","volume":"29","author":"Courchesne-Loyer","year":"2013","journal-title":"Nutrition"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1474-4422(17)30408-8","article-title":"Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders","volume":"17","author":"Augustin","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/MED.0000000000000564","article-title":"Ketogenic diet as a metabolic treatment for mental illness","volume":"27","author":"Norwitz","year":"2020","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21228767","article-title":"Effects of ketone bodies on brain metabolism and function in neurodegenerative diseases","volume":"21","author":"Jensen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1089\/neu.1996.13.473","article-title":"Evaluation of a carbohydrate-free diet for patients with severe head injury","volume":"13","author":"Ritter","year":"1996","journal-title":"J Neurotrauma"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3171\/jns.1991.74.1.0043","article-title":"The effect of glucose administration on carbohydrate metabolism after head injury","volume":"74","author":"Robertson","year":"1991","journal-title":"J Neurosurg"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.clnesp.2021.11.015","article-title":"Phase I single center trial of ketogenic diet for adults with traumatic brain injury","volume":"47","author":"Arora","year":"2022","journal-title":"Clin Nutr ESPEN"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/01616412.2019.1709743","article-title":"Inducing ketogenesis via an enteral formulation in patients with acute brain injury:a phase II study","volume":"42","author":"White","year":"2020","journal-title":"Neurol Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"i5239","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"ref21","volume-title":"The world medical association, Inc","year":"2022"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/epi4.12225","article-title":"Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the international ketogenic diet study group","volume":"3","author":"Kossoff","year":"2018","journal-title":"Epilepsia Open"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/ajcn\/51.2.241","article-title":"A new predictive equation for resting energy expenditure in healthy individuals","volume":"51","author":"Mifflin","year":"1990","journal-title":"Am J Clin Nutr"},{"key":"ref24","year":"2023"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1186\/s13063-018-3004-x","article-title":"Early mobilisation by head-up tilt with stepping versus standard care after severe traumatic brain injury \u2013 protocol for a randomised clinical feasibility trial","volume":"19","author":"Riberholt","year":"2018","journal-title":"Trials"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.seizure.2018.06.019","article-title":"Improving compliance in adults with epilepsy on a modified Atkins diet: a randomized trial","volume":"60","author":"McDonald","year":"2018","journal-title":"Seizure"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0003-9993(99)90271-X","article-title":"Swallowing disorders in severe brain injury: risk factors affecting return to oral intake","volume":"80","author":"Mackay","year":"1999","journal-title":"Arch Phys Med Rehabil"},{"key":"ref28","year":"2022"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0140-6736(74)91639-0","article-title":"Assessment of coma and impaired consciousness","volume":"304","author":"Teasdale","year":"1974","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-015-0469-z","article-title":"The early functional abilities (EFA) scale to assess neurological and neurosurgical early rehabilitation patients","volume":"15","author":"Hankemeier","year":"2015","journal-title":"BMC Neurol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/B0-12-370870-2\/00075-5","article-title":"Disability, functional status, and activities of daily living","author":"Ferrucci","year":"2007","journal-title":"Encyclopedia of Gerontology (Second Edition)"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/02699052.2020.1800094","article-title":"Construct and content validity of the functional Oral intake scale; analyses from a cohort of patients with acquired brain injury","volume":"34","author":"Mortensen","year":"2020","journal-title":"Brain Inj"},{"key":"ref33","volume-title":"Ranchos Los Amigos","author":"Lin","year":"2022"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/pst.185","article-title":"Sample size of 12 per group rule of thumb for a pilot study","volume":"4","author":"Julious","year":"2005","journal-title":"Pharm Stat"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.wneu.2017.09.013","article-title":"Hyponatremia in traumatic brain injury: a practical management protocol","volume":"108","author":"Rajagopal","year":"2017","journal-title":"World Neurosurg"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/bjaceaccp\/mkn019","article-title":"Disorders of sodium balance after brain injury","volume":"8","author":"Bradshaw","year":"2008","journal-title":"Continuing Education in Anaesthesia, Critical Care and Pain"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"626014","DOI":"10.3389\/fneur.2021.626014","article-title":"Early orthostatic exercise by head-up tilt with stepping vs. standard care after severe traumatic brain injury is feasible","volume":"12","author":"Riberholt","year":"2021","journal-title":"Front Neurol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/MCC.0000000000000292","article-title":"Glucose control in acute brain injury: does it matter?","volume":"22","author":"Godoy","year":"2016","journal-title":"Curr Opin Crit Care"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"190556","DOI":"10.1371\/journal.pone.0190556","article-title":"Regional cerebral effects of ketone body infusion with 3-hydroxybutyrate in humans: reduced glucose uptake, unchanged oxygen consumption and increased blood flow by positron emission tomography. A randomized, controlled trial","volume":"13","author":"Svart","year":"2018","journal-title":"PLoS One"},{"key":"ref40","year":"2013"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1177\/1932296815580160","article-title":"Analytical performance requirements for systems for self-monitoring of blood glucose with focus on system accuracy: relevant differences among ISO 15197:2003, ISO 15197:2013, and current FDA recommendations","volume":"9","author":"Freckmann","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/00365513.2022.2054027","article-title":"Evaluation of the point-of-care devices KetoSureTM and StatStrip express\u00ae blood ketone tests using \u03b2-hydroxybutyrate spiked samples","volume":"82","author":"Bjerg","year":"2022","journal-title":"Scand J Clin Lab Invest"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/dia.2010.0116","article-title":"Performance of a new test strip for freestyle blood glucose monitoring systems","volume":"13","author":"Lock","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.pcd.2018.12.010","article-title":"The accuracy evaluation of four blood glucose monitoring systems according to ISO 15197:2003 and ISO 15197:2013 criteria","volume":"13","author":"Chen","year":"2019","journal-title":"Prim Care Diabetes"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1177\/1932296814563351","article-title":"Comparative performance assessment of point-of-care testing devices for measuring glucose and ketones at the patient bedside","volume":"9","author":"Ceriotti","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/14651858.CD001903.pub4","article-title":"Ketogenic diets for drug-resistant epilepsy","volume":"103","author":"Martin-McGill","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"pub5","DOI":"10.1002\/14651858.CD001903.pub5","article-title":"Ketogenic diets for drug-resistant epilepsy","volume":"2020","author":"Martin-McGill","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1573399816999201103141216","article-title":"Hepatic mediators of lipid metabolism and ketogenesis: focus on fatty liver and diabetes","volume":"16","author":"Fernandes","year":"2020","journal-title":"Curr Diabetes Rev"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF00252649","article-title":"The effect of insulin on renal sodium metabolism","volume":"21","author":"DeFronzo","year":"1981","journal-title":"Diabetologia"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1159\/000176515","article-title":"Loss of weight, sodium and water in obese persons consuming a high-or low-carbohydrate diet","volume":"25","author":"Rabast","year":"1981","journal-title":"Ann Nutr Metab"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/MAJ.0b013e318149e6f1","article-title":"Recurrent hyponatremia after traumatic brain injury","volume":"335","author":"Chang","year":"2008","journal-title":"Am J Med Sci"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"10071714","DOI":"10.3390\/cells10071714","article-title":"Brain protection after anoxic brain injury: is lactate supplementation helpful?","volume":"10","author":"Annoni","year":"2021","journal-title":"Cells"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1305888\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T18:07:43Z","timestamp":1710958063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1305888\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":52,"alternative-id":["10.3389\/fmed.2023.1305888"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1305888","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"article-number":"1305888"}}